Clinical Trial Update: TruGraf Utilization in High IPV Levels [NA]

View source ↗

Summary

A University of Maryland–Baltimore led clinical trial evaluating TruGraf use in high IPV levels for kidney transplant recipients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Kidney Transplant; Complications | NA | Status: TERMINATED